Oligonucleotides & mRNA Therapeutics Congress

ChemGenes is proud to be attending and exhibiting at this year’s 10th annual Oligonucleotides & mRNA Therapeutics meeting in Boston, Massachusetts.

OPT Congress is the premier event for scientists and executive directors involved in discovering and developing oligonucleotide and mRNA therapeutics.

For 2025 we are delighted to expand our content and offer a conference program dedicated to emerging oligo modalities, sharing cutting-edge research and technologies used in designing new targeted therapies.

We look forward to seeing you in Boston!